Derek Lowe at In the Pipeline is not so sure that academia is the place for translational research, as both "the process of turning an interesting idea into a real drug target" and that of "turning an interesting compound into a real drug … involve a lot of laborious detail work, of the kind that does not mint fresh PhDs nor energize the postdocs." However, because the National Institutes of Health has recently expressed increased interest in supporting translational research — most recently by funding Clinical and Translational Science Awards at new academic sites, as our sister publicatio

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has approved Kite Pharmaceuticals' CAR T-cell therapy for large B-cell lymphomas, the New York Times reports.

Kaiser Health News reports that gene therapies could cost more than a million dollars.

Worcester Polytechnic Institute researchers have received a grant to combine biology and computer science for high school students.

In Nature this week: variants associated with obsessive-compulsive disorder, review of key CRISPR enzymes, and more.